In this retrospective study of 133 pediatric patients, topical minoxidil was generally well tolerated for managing androgenetic alopecia, but close monitoring and adherence to treatment, accounting for hormonal and concurrent conditions, were emphasized for effective care.
June 2023 in “Brazilian Journal of Health Review” This review discusses the characteristics, causes, diagnosis, and treatment options for androgenetic alopecia and emphasizes the importance of managing expectations due to the variability in therapeutic outcomes.
May 2024 in “Research Square (Research Square)” In this retrospective study from Jiangsu Province Hospital, researchers reported a high prevalence of pediatric androgenetic alopecia in patients under 18, often associated with hormonal imbalances and comorbid conditions, emphasizing the need for individualized treatment plans that prioritize addressing hormonal disorders and comorbidities.
17 citations
,
October 2013 in “F1000Research” This case report details a 2-year-old boy who developed generalized hypertrichosis after using 5% minoxidil foam for alopecia areata, highlighting the importance of caution and proper administration instructions for young children.
January 2023 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This review discusses pediatric androgenetic alopecia and reports no clinical results; the authors highlight a need for diagnostic and treatment options, suggesting further research.